Compendium of Cancer Genome Aberrations

Changes

Volunteer Assignments and Opportunities (view source)

Revision as of 18:07, 21 May 2020

794 bytes added ,  18:07, 21 May 2020
no edit summary
Line 148: Line 148:  
|
 
|
 
|-
 
|-
−
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''|| ||Jennelle Hodge (JH)
+
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Path Resident
−
|
+
|Jennelle Hodge (JH)
 +
|Complete
 
|
 
|
 
|-
 
|-
−
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''|| ||JH
+
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou ||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease|| ||JH
+
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease|| ||JH
+
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease|| ||JH
+
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease|| ||JH
+
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease|| ||JH
+
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou ||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease|| ||JH
+
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+Path Resident||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||JH
+
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+Path Resident
−
|
+
|JH
 +
|Complete
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease|| ||JH
+
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease|| ||JH
+
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease|| ||JH
+
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease|| ||JH
+
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease|| ||JH
+
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease|| ||JH
+
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease|| ||JH
+
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease|| ||JH
+
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng  Choy via Greg Conboy (Monash Health)||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease|| ||JH
+
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease|| ||JH
+
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease|| ||JH
+
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Path Resident  (Iris Martin)||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease|| ||JH
+
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Therapy-Related Myeloid Neoplasms||Disease|| ||JH
+
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''|| ||JH
+
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar  Iqbal||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease|| ||JH
+
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease|| ||JH
+
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease|| ||JH
+
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myelomonocytic Leukemia||Disease|| ||JH
+
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Monoblastic and Monocytic Leukemia||Disease|| ||JH
+
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Pure Erythroid Leukemia||Disease|| ||JH
+
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease|| ||JH
+
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Basophilic Leukemia||Disease|| ||JH
+
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Panmyelosis with Myelofibrosis||Disease|| ||JH
+
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and  Jialing Huang||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Myeloid Sarcoma||Disease|| ||JH
+
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''|| ||JH
+
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease|| ||JH
+
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Leukemia Associated with Down  Syndrome||Disease|| ||JH
+
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease|| ||JH
+
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''|| ||JH
+
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute  Undifferentiated Leukemia||Disease|| ||JH
+
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||JH
+
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease|| ||JH
+
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease|| ||JH
+
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease|| ||JH
+
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH
 
|
 
|
 
|
 
|
Line 780: Line 782:  
|
 
|
 
|-
 
|-
−
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin''''' ||'''''Overview'''''|| ||
+
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||
 
|
 
|
 
|
 
|
Line 852: Line 854:  
|
 
|
 
|-
 
|-
−
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders ||Disease|| ||
+
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders ||Disease|| ||
+
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| '''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
+
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
 
|
 
|
 
|
 
|
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/7933"